Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $631.61 billion, total revenue of $165.59 billion and a weighted average PE ratio of 35.91.
Market Cap
631.61B
Revenue
165.59B
Profits
17.59B
PE Ratio
35.91
Profit Margin
10.62%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 175.85B | -3.17% | 1,682,901 | 44.56B |
| 2 | DHR | Danaher Corporation | 128.46B | -3.27% | 5,856,940 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.46B | -2.61% | 445,252 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.15B | -2.86% | 1,269,660 | 7.07B |
| 5 | WAT | Waters Corporation | 28.37B | -3.79% | 848,343 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 27.50B | -3.28% | 1,526,799 | 16.31B |
| 7 | NTRA | Natera, Inc. | 25.89B | -6.88% | 1,063,048 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 24.95B | -2.99% | 159,659 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.77B | -1.56% | 594,455 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.48B | -1.33% | 976,313 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 17.99B | -5.41% | 1,223,772 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 12.81B | -3.30% | 215,407 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.10B | -3.96% | 2,180,843 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.38B | -3.70% | 835,221 | 2.86B |
| 15 | QGEN | Qiagen N.V. | 8.05B | -1.61% | 1,415,474 | 2.09B |
| 16 | CRL | Charles River Laboratories International, Inc. | 7.84B | -3.62% | 814,218 | 4.02B |
| 17 | ICLR | ICON Public Limited Company | 7.79B | -0.97% | 1,045,774 | 8.10B |
| 18 | RDNT | RadNet, Inc. | 4.36B | -5.49% | 868,313 | 2.04B |
| 19 | SHC | Sotera Health Company | 3.73B | -3.03% | 2,780,169 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.20B | -2.65% | 302,501 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 2.73B | -4.75% | 1,076,448 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.38B | -8.51% | 1,499,981 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 1.99B | -7.04% | 732,256 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.67B | -6.94% | 1,162,882 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 933.35M | -7.35% | 1,703,599 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 859.41M | -3.95% | 551,531 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 850.16M | -4.27% | 3,472,750 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 699.58M | -4.74% | 294,070 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 663.37M | -13.39% | 3,463,111 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 486.89M | -4.76% | 599,129 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 400.21M | -7.36% | 1,617,883 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 344.98M | -3.85% | 154,324 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 176.14M | -11.57% | 32,218 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 140.09M | -2.67% | 65,831 | 88.50M |
| 35 | MDXH | MDxHealth SA | 125.33M | -9.63% | 205,486 | 107.88M |
| 36 | FONR | FONAR Corporation | 121.74M | 0.05% | 91,573 | 106.03M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 114.51M | -13.38% | 341,704 | 4.06M |
| 38 | XGN | Exagen Inc. | 64.46M | -3.94% | 269,564 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 45.50M | -2.15% | 22,439 | 22.80M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 17.98M | -15.61% | 2,821,513 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 11.95M | - | 51,784 | - |
| 42 | NOTV | Inotiv, Inc. | 9.29M | -1.06% | 274,855 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 6.92M | -6.98% | 178,590 | 29.52M |
| 44 | ADVB | Advanced Biomed Inc. | 5.71M | -0.17% | 24,780 | - |
| 45 | QUCY | Mainz Biomed N.V. | 5.51M | -6.22% | 107,026 | 659.94K |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.07M | -5.23% | 63,814 | - |
| 47 | ISPC | iSpecimen Inc. | 1.43M | -7.53% | 1,288,032 | 3.35M |